Elsilimomab
Monoclonal antibody
N
Y (what is this?) (verify) Elsilimomab (also known as B-E8) is a mouse monoclonal antibody.[1] B-E8 was developed by Diaclone,[2] a French company which produces many mouse monoclonal antibodies.
It (OPR-003) targets (and blocks) Interleukin-6.[3]
It has undergone a number of early stage clinical trials, e.g. for lymphoma and myeloma.[4]
It was used as a template to develop a high-affinity, antagonist, fully human anti-IL-6 mAb 1339.[4]
References
- ^ "WHO Drug Information" (PDF). Archived from the original (PDF) on October 16, 2009.
p11:immunoglobulin G1, anti-(human interleukin 6) (mouse monoclonal B-E8 heavy chain), disulfide with mouse monoclonal B-E8 k-chain, dimer
- ^ "Datasheet B-E8 mAb". Diaclone.
- ^ "First Fully Human Anti-IL6 Antibody Under Development". Genetic Engineering & Biotechnology News. Oct 2006.
- ^ a b Fulciniti M, Hideshima T, Vermot-Desroches C, Pozzi S, Nanjappa P, Shen Z, et al. (December 2009). "A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma". Clinical Cancer Research. 15 (23): 7144–52. doi:10.1158/1078-0432.CCR-09-1483. PMC 2787636. PMID 19934301.
- v
- t
- e
Immunosuppressive drugs / Immunosuppressants (L04)
(initiation)
| Antimetabolites |
|
|---|---|
| Macrolides/ other IL-2 inhibitors | |
| IMiDs |
(reception)
| IL-1 receptor antagonists | |
|---|---|
| mTOR |
| Antibodies |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -cept (Fusion) |
- Avacopan
- Baricitinib
- Bimekizumab
- Blisibimod
- Briakinumab
- Brodalumab
- Canakinumab
- Crovalimab
- Danicopan]
- Deucravacitinib
- Efgartigimod alfa (+hyaluronidase)
- Etrasimod
- Filgotinib
- Fingolimod
- Guselkumab
- Iptacopan
- Itacitinib
- Ixekizumab
- Netakimab
- Olokizumab
- Ozanimod
- Peficitinib
- Pegcetacoplan
- Ponesimod
- Ravulizumab
- Risankizumab
- Ritlecitinib
- Rozanolixizumab
- Sarilumab
- Satralizumab
- Siltuximab
- Siponimod
- Sirukumab
- Spesolimab
- Sutimlimab
- Tildrakizumab
- Tofacitinib
- Upadacitinib
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
